-
Chainlink (LINK), UMA (UMA), and API3 (API3) have each shown clear signs of recovery and growth.
-
Each of these oracle tokens has the potential to increase in value in the near future.
-
Below we review each token individually and analyze their price performance and outlook.
Chainlink (LINK), UMA (UMA), and API3 (API3) are established oracle-related tokens that traders and investors were watching on April 13, 2022.
This overview examines their recent price action, historical highs, and short-term potential so you know what to expect in terms of possible growth.
Should you buy Chainlink (LINK)?
On April 13, 2022, Chainlink (LINK) traded at $13.87.
Chainlink’s all-time high occurred on May 10, 2021, when the token reached $52.70.
Reviewing March’s price action, LINK’s low for the month was $12.55 on March 7, while its high was $17.93 on March 31.
That move represents a gain of $5.38, or roughly 43% from the March low to the March high.
Given that momentum, it was reasonable to expect LINK to reach approximately $20 by the end of April 2022, assuming the broader market remained supportive.
Should you buy UMA (UMA)?
On April 13, 2022, UMA was trading at $6.31.
UMA’s all-time high was $41.56 on February 4, 2021.
During March, UMA’s highest price was $11.49 on March 1, while its lowest point was $7.06 on March 11.
This decline represents a drop of $4.43, or about 38% from the early-March high to the mid-March low.
At $6.31, UMA appeared to be recovering value, and many considered the token attractive at that price range, with potential to approach $15 by the end of April 2022 if its recovery continued.
Should you buy API3 (API3)?
On April 13, 2022, API3 traded at $4.08.
API3’s all-time high was $10.30, reached on April 7, 2021.
Looking at March performance, API3’s high for the month was $8.31 on March 1, and its low was $4.45 on March 16. That stretch marked a decline of $3.86, or about 46%.
With a trading price near $4.08, API3 could be viewed as a potentially solid buy given its historical peak and the possibility of a rebound toward $10 by the end of April, contingent on broader market conditions and project fundamentals.